
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Platelet-Rich Plasma
Therapeutic Area : Musculoskeletal
Study Phase : Phase IV
Recipient : Università degli Studi dell'Aquila
Deal Size : Inapplicable
Deal Type : Inapplicable
PRP vs AD-SVF in Addition to Marrow Stimulation for Knee Chondral Lesion
Details : Platelet-Rich Plasma is a Large Molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Knee Chondral Lesion.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
December 01, 2025
Lead Product(s) : Platelet-Rich Plasma
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Recipient : Università degli Studi dell'Aquila
Deal Size : Inapplicable
Deal Type : Inapplicable
